Peter T Clayton Selected Research

2-hydroxyphytanic acid

1/2022

Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-Oxidation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter T Clayton Research Topics

Disease

12	Seizures (Absence Seizure) 01/2019 - 04/2005
10	Epilepsy (Aura) 01/2019 - 04/2005
8	Pyridoxine-dependent epilepsy 01/2021 - 03/2006
6	Brain Diseases (Brain Disorder) 01/2021 - 02/2002
4	Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency 01/2017 - 01/2013
4	Inborn Genetic Diseases (Disease, Hereditary) 06/2016 - 03/2009
3	Ataxia (Dyssynergia) 01/2022 - 01/2013
3	Cerebrotendinous Xanthomatosis 04/2021 - 06/2013
3	Hepatolenticular Degeneration (Wilson's Disease) 01/2017 - 04/2008
3	Congenital Disorders of Glycosylation 06/2016 - 02/2003
3	Hypermanganesemia with Dystonia Polycythemia and Cirrhosis 01/2016 - 03/2012
3	Dystonia (Limb Dystonia) 01/2016 - 09/2012
3	Inborn Errors Metabolism (Inborn Errors of Metabolism) 02/2015 - 04/2006
3	Jaundice (Icterus) 09/2014 - 02/2002
3	Liver Diseases (Liver Disease) 09/2014 - 02/2002
3	Cholestasis 01/2010 - 08/2002
2	Smith-Lemli-Opitz Syndrome 01/2021 - 01/2017
2	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 12/2019 - 07/2019
2	Metabolic Diseases (Metabolic Disease) 01/2016 - 08/2011
2	Parkinsonian Disorders (Parkinsonism) 01/2016 - 08/2011
2	Beta-Hydroxyisobutyryl CoA Deacylase Deficiency 12/2013 - 01/2007
2	Pyruvate Dehydrogenase Complex Deficiency Disease 12/2013 - 08/2005
2	Molybdenum cofactor deficiency 11/2012 - 04/2011
2	Fibrosis (Cirrhosis) 09/2012 - 01/2010
2	Nervous System Diseases (Neurological Disorders) 08/2011 - 04/2005
2	Hepatomegaly 01/2010 - 02/2002
1	Fatty Liver 01/2022
1	Refsum Disease (Refsum's Disease) 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2019
1	Optic Atrophy 01/2019
1	Hypophosphatasia 01/2019
1	Neoplasms (Cancer) 01/2017
1	Cognitive Dysfunction 10/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2016
1	Congenital disorder of glycosylation type II 06/2016
1	Muscular Dystrophies (Muscular Dystrophy) 06/2016
1	Fever (Fevers) 01/2016
1	Exocrine Pancreatic Insufficiency 01/2016
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2016
1	Channelopathies 01/2016
1	Vomiting 01/2016
1	Primary Hyperoxaluria (Oxaluria, Primary) 10/2015
1	Mitochondrial encephalopathy 04/2015
1	Muscle Spasticity (Spastic) 11/2014
1	Paresis (Hemiparesis) 11/2014
1	Hereditary Spastic Paraplegia 09/2014

Drug/Important Bio-Agent (IBA)

12	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2021 - 04/2005
10	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 04/2005
9	EnzymesIBA 01/2022 - 07/2010
9	PyridoxalIBA 01/2019 - 04/2005
7	Bile Acids and Salts (Bile Acids)IBA 04/2021 - 04/2008
7	ManganeseIBA 01/2017 - 04/2008
6	CholesterolIBA 04/2021 - 06/2013
5	Vitamin B 6IBA 01/2019 - 01/2013
5	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 04/2017 - 04/2005
5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016 - 10/2007
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019 - 04/2005
3	OxysterolsIBA 01/2017 - 09/2014
3	Proteins (Proteins, Gene)FDA Link 06/2016 - 07/2010
3	allysineIBA 07/2010 - 03/2006
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2022 - 09/2014
2	SterolsIBA 04/2021 - 01/2017
2	7-dehydrocholesterolIBA 01/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 07/2019 - 01/2010
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 12/2016
2	IronIBA 01/2017 - 12/2013
2	Nonsense Codon (Nonsense Mutation)IBA 12/2016 - 05/2009
2	Glycoproteins (Glycoprotein)IBA 06/2016 - 07/2013
2	Chenodeoxycholic Acid (Chenix)FDA Link 09/2014 - 01/2010
2	Valine (L-Valine)FDA Link 12/2013 - 01/2007
1	AcidsIBA 01/2022
1	phytanoyl-coenzyme A (phytanoyl CoA)IBA 01/2022
1	2-hydroxyphytanic acidIBA 01/2022
1	margaric acid (heptadecanoic acid)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2021
1	Sulfates (Sulfates, Inorganic)IBA 07/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2019
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2019
1	Copper Transport ProteinsIBA 01/2017
1	7-dehydrocholesterol reductaseIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	ZincIBA 01/2017
1	Proline (L-Proline)FDA Link 12/2016
1	Ligases (Synthetase)IBA 12/2016
1	Transaminases (Aminotransferases)IBA 10/2016
1	LipidsIBA 06/2016
1	Congenital disorder of glycosylation type 1AIBA 06/2016
1	Ceruloplasmin (Ferroxidase)IBA 06/2016
1	ElectrolytesIBA 01/2016
1	TransferasesIBA 01/2016
1	Transfer RNA (tRNA)IBA 01/2016
1	Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA 10/2015
1	PyridoxamineIBA 10/2015
1	Serine (L-Serine)FDA Link 04/2015
1	cholestenoic acidIBA 11/2014
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 09/2014

Therapy/Procedure

2	Therapeutics 01/2019 - 10/2015
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016
1	Aftercare (After-Treatment) 01/2016